Genesis MedTech, a leading medical device company headquartered in Singapore, has secured marketing approvals from China’s National Medical Products Administration (NMPA) for two of its high-frequency electrosurgical energy products: the “OP9 ultrasonic high frequency integrated surgical equipment” and the “disposable cutting and closing knife head.” The OP9 device is a groundbreaking integrated energy platform capable of delivering both ultrasound energy and high-frequency electrical energy, marking it as the world’s first device with dual interfaces and a 7mm vascular occlusion function.
This innovative device can be interfaced with Genesis MedTech’s existing range of ultrasound cutting heads, catering to various surgical procedures when operating in ultrasound mode. In high-frequency mode, it can be connected to the disposable knife head, which is designed to safely occlude blood vessels and lymphatic vessels of 7mm or less in diameter. The OP9 and its associated knife head utilize intelligent algorithms to control energy output, offering a sophisticated design and user-friendly operation. These products are engineered to handle more tissue in a single procedure, thereby reducing surgical time and enhancing the ease of surgical operations for medical professionals. – Flcube.com
